Drugs News and Research

RSS

Autism diagnosis patterns change as psychiatric profiles shift across Europe

The medical profiles of adults diagnosed with autism have changed hugely since 2010, finds a study of medical records in the UK and Sweden, published in the online journal BMJ Mental Health.

3 Nov 2026

Engineered beneficial bacteria reduce bloodstream infections after stem cell transplants

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, and collaborators have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers.

3 Nov 2026

Synthetic DNA molecules enable precise targeting of cancer-linked genes

Researchers have developed a promising new approach that uses synthetic DNA molecules to target cancer-linked genes directly, opening new possibilities for future treatments, diagnostics and biological research.

3 Nov 2026

A low-calorie diet and exercise helped 54% of younger adults achieve diabetes remission

In a randomized clinical trial involving 96 adults with early-onset type 2 diabetes and obesity, a 24-week program combining a low-energy diet with supervised exercise achieved diabetes remission in 54% of participants, compared with 4% receiving usual care. The intervention also reduced body fat, largely preserved muscle mass, and improved strength and body-mass-adjusted fitness, although the additional benefits attributable specifically to exercise remain uncertain.

3 Nov 2026

Alliance for Clinical Trials in Oncology highlights key role of clinical research in advancing men's cancer care

Every November, millions worldwide grow mustaches and join Movember, a global movement launched in 2003 to spark conversations about men's health, including prostate cancer, testicular cancer, and mental health.

3 Nov 2026

1nhaler secures £2.2 million to continue late-stage development

The 1nhaler, a Scotland-based drug delivery device developer, has secured £2.2 million in follow-on funding to progress its novel pop-up cardboard inhaler towards first regulatory approval.

3 Nov 2026

New study identifies biological mechanism driving therapy resistance in advanced prostate cancer

A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls cell identity and treatment resistance in advanced prostate cancer.

3 Nov 2026

RNA-protein interactions reveal new coronavirus drug targets

A study led by researchers at the University of California San Diego School of Medicine and University of California, Riverside (UCR) School of Medicine has identified new targets for antiviral drugs against coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.

3 Nov 2026

Key innate immune protein regulates cholesterol and influences cancer treatment resistance

Scientists at the University of North Carolina Lineberger Comprehensive Cancer Center have discovered an unexpected role for a key innate immune protein, revealing how it helps regulate cholesterol levels inside cells and influences tumor growth and treatment response.

3 Nov 2026

Plant-derived compound helps restore cancer cells' sensitivity to treatment

A natural plant compound may help overcome a built-in defense that allows many cancers to resist a class of drugs designed to restore normal gene activity, according to a study by researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

2 Nov 2026

Scientists may have underestimated how much genes contribute to Alzheimer's risk

A large multi-ancestry genetic analysis identified 127 genomic loci associated with Alzheimer's disease, including 48 previously unreported loci, and implicated microglial and neuronal gene-expression patterns in disease susceptibility. The researchers estimated that common genetic variants account for 16% of Alzheimer's disease liability in European-ancestry populations, substantially higher than previous estimates, while demonstrating improved polygenic risk prediction that remained less reliable in non-European populations.

2 Nov 2026

New hormone receptor strategy offers targeted treatment for lupus

Researchers at the University of California, Riverside and City of Hope have identified a new strategy for treating systemic lupus erythematosus (SLE), or lupus, an autoimmune disease in which the immune system attacks healthy tissues.

2 Nov 2026

Study identifies new targets for antiviral drugs against coronaviruses

2 Nov 2026

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Dr. Laura Ajram leads the British Neuroscience Association, focusing on enhancing neuroscience research through strategic partnerships and patient engagement.

2 Nov 2026

Targeting EGFR signaling to reduce mucus overproduction in lung diseases

Airway mucus is part of innate lung defense, but when production overwhelms clearance, it obstructs airflow and worsens disease.

2 Nov 2026

Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trials

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced the publication of a peer-reviewed Viewpoint in the European Respiratory Journal (ERJ).

From Qureight 2 Nov 2026

Could GLP-1 drugs help women with PCOS beyond weight loss?

A scoping review of 28 studies suggests that GLP-1 receptor agonists may improve androgen levels and menstrual function in women with polycystic ovary syndrome (PCOS), alongside their established metabolic benefits. Evidence for improved ovulation, fertility, and pregnancy outcomes remains limited, and the researchers could not determine whether reproductive benefits result directly from the drugs or from weight loss and improved metabolic health.

1 Nov 2026

Why you still want dessert even when you're completely full

A 2026 narrative review examines how food liking (pleasure) and wanting (motivation) interact with hunger and satiety to influence food choices, explaining why certain foods may remain appealing even after a satisfying meal. The authors report that food reward can change independently of hunger under specific conditions, but evidence remains limited that these changes reliably predict subsequent eating or improve weight-management outcomes.

1 Nov 2026

New database offers insights into psychedelic use outside clinical trials

Fireside Project today announced the publication of "The Fireside Database: Large-Scale Evidence from 25,419 Psychedelic Support Interactions" in Science Advances, providing researchers and policymakers with an unprecedented empirical window into psychedelic use and support outside clinical settings.

30 Oct 2026

Hemoadsorption may improve outcomes in severe poisoning cases

The WHO estimated over 800,000 suicide deaths in 2012, with poisoning a major concern. Three‑quarters of suicides occur in low‑ and middle‑income countries, with an estimated 30% related to pesticides.

30 Oct 2026

Drugs News and Research

Autism diagnosis patterns change as psychiatric profiles shift across Europe

Engineered beneficial bacteria reduce bloodstream infections after stem cell transplants

Synthetic DNA molecules enable precise targeting of cancer-linked genes

A low-calorie diet and exercise helped 54% of younger adults achieve diabetes remission

Alliance for Clinical Trials in Oncology highlights key role of clinical research in advancing men's cancer care

1nhaler secures £2.2 million to continue late-stage development

New study identifies biological mechanism driving therapy resistance in advanced prostate cancer

RNA-protein interactions reveal new coronavirus drug targets

Key innate immune protein regulates cholesterol and influences cancer treatment resistance

Plant-derived compound helps restore cancer cells' sensitivity to treatment

Scientists may have underestimated how much genes contribute to Alzheimer's risk

New hormone receptor strategy offers targeted treatment for lupus

Study identifies new targets for antiviral drugs against coronaviruses

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Targeting EGFR signaling to reduce mucus overproduction in lung diseases

Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trials

Could GLP-1 drugs help women with PCOS beyond weight loss?

Why you still want dessert even when you're completely full

New database offers insights into psychedelic use outside clinical trials

Hemoadsorption may improve outcomes in severe poisoning cases

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News